SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,029,000 | -46.8% | 248,610 | -25.4% | 0.01% | -54.5% |
| Q1 2022 | $1,935,000 | -78.9% | 333,082 | -43.4% | 0.01% | -85.7% |
| Q4 2020 | $9,185,000 | +2562.3% | 588,624 | +1430.7% | 0.08% | +1825.0% |
| Q2 2020 | $345,000 | +255.7% | 38,454 | +277.4% | 0.00% | +33.3% |
| Q1 2019 | $97,000 | -94.8% | 10,190 | -89.6% | 0.00% | -93.2% |
| Q1 2018 | $1,867,000 | -45.1% | 98,244 | -52.6% | 0.04% | -40.5% |
| Q4 2017 | $3,402,000 | – | 207,433 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |